LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 4, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2022

Conditions
Metastatic Pancreatic Adenocarcinoma
Interventions
DRUG

LEE011

Treatment cycles are 28 days long. It is taken orally. The dosage varies depending on the study arm.

DRUG

Everolimus

Treatment cycles are 28 days long. It is taken orally. On all arms, the dosage will be 2.5mg.

Trial Locations (1)

20007

Lombardi Comprehensive Cancer Center, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Georgetown University

OTHER

collaborator

Novartis

INDUSTRY

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

Virginia Mason Hospital/Medical Center

OTHER